📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. (2021)

First Author: Garcia-Montojo M

Attributed to: JPND Biological Resource Analysis to Identify New MEchanisms and phenotypes in Neurodegenerative Diseases (BRAIN-MEND) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2021.117358

PubMed Identifier: 33653604

Publication URI: http://europepmc.org/abstract/MED/33653604

Type: Journal Article/Review

Volume: 423

Parent Publication: Journal of the neurological sciences

ISSN: 0022-510X